Market Overview The latex particle enhanced turbidimetric immunoassay PETIA market is advancing as cardiovascular biomarker quantification supports risk stratification with high-sensitivity measurement. The Latex Particle Enhanced Turbidimetric Immunoassay PETIA Market is projected to reach $3.5 billion by 2035, growing at 5.9% CAGR, driven by hsCRP adoption, lipid panel integration, and demand...